IRIS
1.5 Abstract in rivista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 19.410
NA - Nord America 9.337
EU - Europa 4.018
SA - Sud America 1.272
AF - Africa 192
Continente sconosciuto - Info sul continente non disponibili 109
OC - Oceania 94
Totale 34.432
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 13.993
US - Stati Uniti d'America 8.948
CN - Cina 2.292
IT - Italia 1.996
HK - Hong Kong 1.309
BR - Brasile 940
GB - Regno Unito 614
VN - Vietnam 543
FR - Francia 492
BD - Bangladesh 327
IN - India 304
DE - Germania 266
CA - Canada 207
AR - Argentina 143
NL - Olanda 112
ID - Indonesia 98
TR - Turchia 98
MX - Messico 90
AU - Australia 66
EC - Ecuador 58
CZ - Repubblica Ceca 57
FI - Finlandia 57
EE - Estonia 54
JP - Giappone 51
PK - Pakistan 50
UA - Ucraina 50
PL - Polonia 44
ES - Italia 43
SA - Arabia Saudita 43
ZA - Sudafrica 43
IQ - Iraq 39
CO - Colombia 37
MY - Malesia 35
PH - Filippine 35
EG - Egitto 32
CL - Cile 30
RU - Federazione Russa 29
PY - Paraguay 25
JM - Giamaica 23
MD - Moldavia 23
NZ - Nuova Zelanda 22
TW - Taiwan 20
AE - Emirati Arabi Uniti 19
AT - Austria 19
IE - Irlanda 19
SE - Svezia 19
NP - Nepal 17
VE - Venezuela 17
ET - Etiopia 16
MA - Marocco 16
TN - Tunisia 16
DO - Repubblica Dominicana 14
TH - Thailandia 14
AZ - Azerbaigian 12
CH - Svizzera 12
UZ - Uzbekistan 12
IR - Iran 11
KZ - Kazakistan 11
LT - Lituania 11
UY - Uruguay 11
KE - Kenya 10
KW - Kuwait 10
DK - Danimarca 9
HN - Honduras 9
OM - Oman 9
PT - Portogallo 9
BE - Belgio 8
CR - Costa Rica 8
GH - Ghana 8
HU - Ungheria 8
KR - Corea 8
NO - Norvegia 8
RO - Romania 8
AL - Albania 7
DZ - Algeria 7
GT - Guatemala 7
IL - Israele 7
NG - Nigeria 7
PE - Perù 7
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
GR - Grecia 5
JO - Giordania 5
KG - Kirghizistan 5
LY - Libia 5
PR - Porto Rico 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
BH - Bahrain 4
BO - Bolivia 4
KH - Cambogia 4
LB - Libano 4
LK - Sri Lanka 4
MK - Macedonia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
AO - Angola 3
BB - Barbados 3
CI - Costa d'Avorio 3
Totale 34.250
Salva come PNG Salva come JPEG
Città #
San Jose 2.796
Singapore 1.768
Ashburn 1.573
Rome 1.411
Hong Kong 1.285
Hefei 986
Council Bluffs 690
Dallas 685
Boardman 583
Columbus 499
London 464
Beijing 450
Lauterbourg 432
Shanghai 342
Ho Chi Minh City 204
Los Angeles 181
New York 151
Santa Clara 130
Hanoi 128
San Francisco 124
Pune 114
São Paulo 90
West Jordan 90
Milan 76
Munich 70
Amsterdam 69
Toronto 62
Washington 62
Seattle 50
Chicago 46
Brooklyn 42
Mexico City 42
Brno 41
Phoenix 40
Warsaw 37
Sona 36
Montreal 35
Turku 35
Las Vegas 34
Naples 34
Tokyo 33
Buffalo 31
Frankfurt am Main 30
Rio de Janeiro 28
Chennai 25
Haiphong 24
Riyadh 23
Helsinki 22
Melbourne 22
Jakarta 21
Quito 21
Brasília 20
Da Nang 20
Atlanta 19
Kuala Lumpur 19
Orem 19
Canberra 18
Guayaquil 18
Hanover 18
Manchester 18
Nuremberg 18
Buenos Aires 17
Florence 17
Istanbul 17
New Delhi 17
Paris 17
Baghdad 16
Boston 16
Charlotte 16
Johannesburg 16
Porto Alegre 15
Stockholm 15
Sydney 15
Thái Bình 15
Bologna 14
Cairo 14
Curitiba 14
Dhaka 14
Hải Dương 14
Jeddah 14
Philadelphia 14
Central 13
Turin 13
Ankara 12
Biên Hòa 12
Dublin 12
Kingston 12
Addis Ababa 11
Bangkok 11
Belo Horizonte 11
Campinas 11
Manila 11
Ninh Bình 11
Vienna 11
Baku 10
Brescia 10
Catania 10
Glasgow 10
Olomouc 10
Pittsburgh 10
Totale 16.972
Salva come PNG Salva come JPEG
Nome #
PLASTIC IN PLACENTA: WHAT IS IT? WHAT TO DO? 436
112P Measuring time-toxicity and prognostic impact of hospital attendance in early phase cancer trials participants 338
18F-Choline PET/CT for early detection of prostate cancer recurrence after radical prostatectomy 333
1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC) 314
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy 312
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 305
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 256
69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors 255
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 249
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 244
A new adjunct for emergency airway management:the Laryngeal Tube, preliminary data 242
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 239
Effect of hypothermia on human colonic smooth muscle contractility 236
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY 235
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 234
Purse-String Closure vs Conventional Direct Closure of Wounds after Stoma Reversal: A Prospective Randomized Controlled Study 231
A biomechanical index for the evaluation of upper arm motor control in a subject affected by polyradiculoneuropathy 230
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 227
Disclosing 3D Shape of Ossa Genitalia in Primates 222
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 222
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 220
P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study 219
Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy 219
Gait Speed Is a Valid Indicator in the Assessment of Perioperative Risk in the Elderly Surgical Patient 216
3D Bioprinting of Human Skin and Squamous Cell Tumors (SCCs) as Advanced Models for Precision Medicine (BIOSQIN) 215
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 215
EP24.13: Fetomaternal hemorrhage: a new hypothesis on the importance of fetal vasoconstriction – a case report 213
Chronotherapy and surgery for unresectable hepatic metastases from colorectal cancer 213
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 212
Diagnosis of labour: the II prospective clinical study 211
Does HE4 have a role in the recurrence of ovarian cancer? 211
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 210
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 206
APPLICATION OF RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION(RITA) IN "NO CLAMP-NO SUTURE" LAPAROSCOPIC PARTIAL NEPHRECTOMY 206
Assessment of liver function by the exhaled breath-print during chronic liver disease 206
Aligned electrospun poly-l-lactide fibers for tendon regeneration: a preliminary in vitro study 206
Risultati preliminari dell’uso della risonanza magnetica nello studio dei disturbi dell’evacuazione 202
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 195
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 194
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 193
The Hendrich II model for assessing the risk of falls for hospitalized patients [Il modello Hendrich II per la valutazione del rischio di cadute per pazienti ospedalizzati] 192
Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis 189
Biomimetic Polyurethane Scaffolds Guiding the In Vitro Behavior of Cardiac Stem Cells 189
534 Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 182
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 175
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY. 167
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 153
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 151
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 151
A polysaccharide foam-like scaffold obtained by crosslinking lactose-modified chitosan and oxidized hyaluronan 148
Abruptio placenta and TLRs 2-3-4 147
A case of synchronous hepatic and gastric malignancies: diagnostic problems and therapeutical strategies 143
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm 142
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 142
Alimentazione e gravidanza fisiologica 141
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 141
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) 140
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 135
GH-resistance in different stages of chronic liver disease 135
A New Technique for Laparoscopic Stripping of Endometriomas: FloSeal Hemostatic Agent for Hemostasis of the Ovarian Wall 134
"NO CLAMP NO SUTURE'' LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL EXOPHYTIC RENAL TUMORS 132
A Systematic Review of the Role of Lymphadenectomy in Pancreatic Cancer 131
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 129
Biological effects of cabozantinib on bone microenvironment 128
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 127
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade 126
A meta-synthesis of experiences of caregivers of people with COPD. 126
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer. 125
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 125
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 125
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 124
5-YEAR ONCOLOGIC OUTCOMES FOR ROBOT-ASSISTED AND LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HIGH-RISK RENAL TUMORS 124
Fetal head-symphysis distance: a simple and reliable ultrasound parameter for the intrapartum assessment of the fetal head descent 123
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 122
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 122
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 122
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 122
The ability of Lung High-Resolution Computed Tomography Severity Score to early identify COVID-19 patients who need respiratory support. A retrospective analysis of a monocentric Italian COVID-19 cohort 120
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: techniqueand feasibility. 119
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 119
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 119
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 119
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 119
How long is the latent phase of labour? 118
"NO CLAMPING-NO SUTURING" LAPAROSCOPIC PARTIAL NEPHRECTOMY (LPN). 118
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 118
Baccalaureate nursing students’ attitudes towards old people 117
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 116
Amniotic membrane produces and releases nerve growth factor (NGF) and expresses NGF receptors 115
T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATED LIVER INJURY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA COMPARED TO PATIENTS WITH ADVANCED SOLID TUMOURS 114
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 114
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 114
Integrated treatment of pancreatic head carcinoma 114
ALT levels are associated with metabolic parameters and age in a large real-life population. 113
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 111
Combined multimodality treatment of primary or recurrent locally advanced rectal cancer 109
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 109
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 105
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 105
Adjuvant external and intraoperative radiation therapy in resectable pancreatic cancer 105
Totale 17.402
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022708 0 0 11 6 57 8 6 3 24 32 13 548
2022/2023387 29 11 8 32 43 26 33 22 24 35 108 16
2023/20241.848 82 163 75 113 203 818 33 84 22 135 35 85
2024/202515.416 230 198 621 65 107 342 218 69 1.260 1.172 5.231 5.903
2025/202614.752 1.366 507 1.119 1.671 536 1.026 4.469 725 998 1.110 676 549
2026/20271.321 162 1.159 0 0 0 0 0 0 0 0 0 0
Totale 34.432